Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 5Completed 5Active not recruiting 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Classical hematology 1

Conditions

Breast Neoplasms 192Neoplasms 148Prostatic Neoplasms 101Lung Neoplasms 90Carcinoma, Non-Small-Cell Lung 62Colorectal Neoplasms 59Head and Neck Neoplasms 52Pancreatic Neoplasms 46Carcinoma, Hepatocellular 44Rectal Neoplasms 42Brain Neoplasms 41Multiple Myeloma 40Colonic Neoplasms 37Esophageal Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 30Leukemia, Myeloid, Acute 30Ovarian Neoplasms 29Lymphoma, Non-Hodgkin 29Leukemia 29Lymphoma 28Motor Activity 26Hodgkin Disease 24Uterine Cervical Neoplasms 23Carcinoma, Renal Cell 23Pain 22Lymphoma, Follicular 22Depression 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioma 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Coronary Artery Disease × Clear all
NCT05315908 2024-02-28

COVID-19 Testing in Underserved and Vulnerable Populations

University of California, San Diego

Phase NA Terminated
9,120 enrolled 8 charts
Classical hematologyOther

Anemia, Sickle Cell, Coronary Artery Disease, Diabetes Mellitus, Type 2, Heart Failure, Neoplasms, Obesity, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡